SHSE:600420 (China)
Â
Class A
Â¥
10.32
-0.020 (-0.19%)
Apr 25
What is a stock summary page? Click here for an overview.
Business Description
Shanghai Shyndec Pharmaceutical Co Ltd
ISIN : CNE000001JG2
Share Class Description:
SHSE:600420: Class ACompare
Compare
Traded in other countries / regions
600420.China Index Membership
SSE Composite Index IPO Date
2004-06-16Description
Shanghai Shyndec Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical preparations, biological pharmaceuticals, chemical raw materials, and Chinese medicine formulations in China and internationally. It provides biological and chemical raw material medicines, microbial fermentation products and tablets, capsules, granules, injections, suspensions, and suppositories, as well as ointments, including product formulations.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.46 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | 0.67 | |||||
| Interest Coverage | 48.7 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 3.5 | |||||
| Beneish M-Score | -2.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -11.7 | |||||
| 3-Year EBITDA Growth Rate | 5.6 | |||||
| 3-Year EPS without NRI Growth Rate | 22.5 | |||||
| 3-Year FCF Growth Rate | 15.6 | |||||
| 3-Year Book Growth Rate | 5.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.63 | |||||
| 9-Day RSI | 47.19 | |||||
| 14-Day RSI | 42.46 | |||||
| 3-1 Month Momentum % | -1.63 | |||||
| 6-1 Month Momentum % | -6.99 | |||||
| 12-1 Month Momentum % | 7.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.69 | |||||
| Quick Ratio | 2.18 | |||||
| Cash Ratio | 1.43 | |||||
| Days Inventory | 124.49 | |||||
| Days Sales Outstanding | 42.91 | |||||
| Days Payable | 80.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.94 | |||||
| Dividend Payout Ratio | 0.22 | |||||
| 3-Year Dividend Growth Rate | 26 | |||||
| Forward Dividend Yield % | 1.94 | |||||
| 5-Year Yield-on-Cost % | 3.18 | |||||
| 3-Year Average Share Buyback Ratio | -9.3 | |||||
| Shareholder Yield % | 4.75 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 39.24 | |||||
| Operating Margin % | 16.43 | |||||
| Net Margin % | 9.91 | |||||
| FCF Margin % | 18.62 | |||||
| ROE % | 8.42 | |||||
| ROA % | 5.46 | |||||
| ROIC % | 13.83 | |||||
| 3-Year ROIIC % | -112.66 | |||||
| ROC (Joel Greenblatt) % | 25.46 | |||||
| ROCE % | 11.11 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 12.77 | |||||
| Forward PE Ratio | 10.02 | |||||
| PE Ratio without NRI | 11.28 | |||||
| Shiller PE Ratio | 15.4 | |||||
| Price-to-Owner-Earnings | 17.7 | |||||
| PEG Ratio | 12.53 | |||||
| PS Ratio | 1.26 | |||||
| PB Ratio | 1.05 | |||||
| Price-to-Tangible-Book | 1.14 | |||||
| Price-to-Free-Cash-Flow | 6.8 | |||||
| Price-to-Operating-Cash-Flow | 6.14 | |||||
| EV-to-EBIT | 6.38 | |||||
| EV-to-EBITDA | 6.38 | |||||
| EV-to-Revenue | 1 | |||||
| EV-to-FCF | 5.29 | |||||
| Price-to-GF-Value | 1.25 | |||||
| Price-to-Projected-FCF | 0.54 | |||||
| Price-to-Median-PS-Value | 1.29 | |||||
| Price-to-Graham-Number | 0.76 | |||||
| Price-to-Net-Current-Asset-Value | 2.8 | |||||
| Earnings Yield (Greenblatt) % | 15.67 | |||||
| FCF Yield % | 14.71 | |||||
| Forward Rate of Return (Yacktman) % | 13.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Shyndec Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 10,937.525 | ||
| EPS (TTM) (Â¥) | 0.808 | ||
| Beta | 1.13 | ||
| 3-Year Sharpe Ratio | -0.02 | ||
| 3-Year Sortino Ratio | -0.04 | ||
| Volatility % | 34.98 | ||
| 14-Day RSI | 42.46 | ||
| 14-Day ATR (Â¥) | 0.200475 | ||
| 20-Day SMA (Â¥) | 10.3095 | ||
| 12-1 Month Momentum % | 7.21 | ||
| 52-Week Range (Â¥) | 9.69 - 14.41 | ||
| Shares Outstanding (Mil) | 1,341.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Shyndec Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Shyndec Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Shyndec Pharmaceutical Co Ltd Frequently Asked Questions
What is Shanghai Shyndec Pharmaceutical Co Ltd(SHSE:600420)'s stock price today?
The current price of SHSE:600420 is ¥10.32. The 52 week high of SHSE:600420 is ¥14.41 and 52 week low is ¥9.69.
When is next earnings date of Shanghai Shyndec Pharmaceutical Co Ltd(SHSE:600420)?
The next earnings date of Shanghai Shyndec Pharmaceutical Co Ltd(SHSE:600420) is .
Does Shanghai Shyndec Pharmaceutical Co Ltd(SHSE:600420) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Shyndec Pharmaceutical Co Ltd(SHSE:600420) is 1.94% (As of Today), Highest Dividend Payout Ratio of Shanghai Shyndec Pharmaceutical Co Ltd(SHSE:600420) was 0.34. The lowest was 0.1. And the median was 0.22. The  Forward Dividend Yield % of Shanghai Shyndec Pharmaceutical Co Ltd(SHSE:600420) is 1.94%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers